Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | Patent Publication Number 20180282414

US 20180282414 A1
Patent NumberUS 10323092 B2
Application Number16006493
Filled DateJun 12, 2018
Priority DateMay 15, 2012
Publication DateOct 4, 2018
Original AssigneeBristol Myers Squibb
Current AssigneeBristol Myers Squibb
Inventor/ApplicantsAshok K. Gupta
Maria Jure-Kunkel
John P. COGSWELL
Jon M. Wigginton
Xi-Tao Wang
Stacie M. Goldberg
John P. Cogswell
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.